Senti Biosciences: pres. & chief med./dev. off. Rajangam Kanya sold 19,953 shares

What happened Rajangam Kanya, president and chief medical and development officer, reported a payment of exercise price or tax liability (transaction code F). The Form 4 shows 19,953 shares were disposed at $0.00 per share, total $0. Footnote F1 states the shares were withheld by the issuer to satisfy income tax withholding in connection with net settlement of certain time-based restricted stock unit awards and do not represent an open market sale.

Key details

• Transaction date: Oct 21, 2026; price per share: $0.00; shares involved: 19,953; total reported value: $0.
• Filing date: Oct 23, 2026.
• Shares owned after the transaction: not specified in the provided filing excerpt.
• Footnote F1: shares were withheld by the issuer to satisfy income tax withholding related to net-settled time-based RSUs; not an open market sale.
• The provided filing does not include a late-filing indicator.

Why it may matter

• The transaction reported is a tax-withholding event tied to net settlement of restricted stock units, not an open market sale.
• This filing does not show why the insider traded or why the company acted.